Zobrazeno 1 - 10
of 79
pro vyhledávání: '"James L. Bown"'
Publikováno v:
BioDiscovery, Vol 9, Iss , Pp 1-32 (2013)
The DNA Damage Response (DDR) pathway represents a signalling mechanism that is activated in eukaryotic cells following DNA damage and comprises of proteins involved in DNA damage detection, DNA repair, cell cycle arrest and apoptosis. This pathway c
Externí odkaz:
https://doaj.org/article/eeab7ab31c85464587222c36a0cf1edd
Autor:
Ben C. Stevenson, Peter D. Caie, Janine B. Illian, David J. Harrison, Anne Savage, Charlotte M. Jones-Todd, James L. Bown
Publikováno v:
Statistics in Medicine. 38:1421-1441
Diagnosis and prognosis of cancer are informed by the architecture inherent in cancer patient tissue sections. This architecture is typically identified by pathologists, yet advances in computational image analysis facilitate quantitative assessment
Autor:
Andrei Boiko, Mark Shovman, David J. Harrison, Peter Mullen, Paul Robertson, Alexey Goltsov, James L. Bown
Publikováno v:
Oncotarget
// James L. Bown 1, 2 , Mark Shovman 2, 4 , Paul Robertson 2 , Andrei Boiko 1, 2 , Alexey Goltsov 1 , Peter Mullen 3 , David J. Harrison 3 1 School of Science, Engineering and Technology, Abertay University, Dundee, DD1 1HG, UK 2 School of Arts, Medi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::296c0ac94aef50a223312efb7ac01e1b
https://hdl.handle.net/10023/9005
https://hdl.handle.net/10023/9005
Autor:
Tero Soininen, Hilal S. Khalil, David J. Harrison, Alexey Goltsov, Yusuf Y. Deeni, Simon P. Langdon, James L. Bown
Publikováno v:
Oncotarget
Khalil, H S, Langdon, S, Goltsov, A, Soininen, T, Harrison, D, Bown, J & Deeni, Y 2016, ' A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells ', Oncotarget . https://doi.org/10.18632/oncotarget.12425
Khalil, H S, Langdon, S, Goltsov, A, Soininen, T, Harrison, D, Bown, J & Deeni, Y 2016, ' A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells ', Oncotarget . https://doi.org/10.18632/oncotarget.12425
// Hilal S. Khalil 1 , Simon P. Langdon 3 , Alexey Goltsov 1 , Tero Soininen 1 , David J. Harrison 4 , James Bown 2 , Yusuf Y. Deeni 1 1 Division of Science, School of Science, Engineering and Technology, Abertay University, Dundee, DD1 1HG, United K
Autor:
Charlotte M, Jones-Todd, Peter, Caie, Janine B, Illian, Ben C, Stevenson, Anne, Savage, David J, Harrison, James L, Bown
Publikováno v:
Statistics in medicine. 38(8)
Diagnosis and prognosis of cancer are informed by the architecture inherent in cancer patient tissue sections. This architecture is typically identified by pathologists, yet advances in computational image analysis facilitate quantitative assessment
Autor:
Susan Stepney, Fiona A.C. Polack
This book describes CoSMoS (Complex Systems Modelling and Simulation), a pattern-based approach to engineering trustworthy simulations that are both scientifically useful to the researcher and scientifically credible to third parties. This approach e
Autor:
Hilal S. Khalil, David J. Harrison, Simon P. Langdon, Yusuf Y. Deeni, James L. Bown, Alexey Goltsov
Publikováno v:
Journal of Biotechnology. 202:12-30
Cells are constantly exposed to Reactive Oxygen Species (ROS) produced both endogenously to meet physiological requirements and from exogenous sources. While endogenous ROS are considered as important signalling molecules, high uncontrollable ROS are
Autor:
Alexey Goltsov, James L. Bown
Publikováno v:
Narrating Complexity ISBN: 9783319647128
We explore the role of narratives of complex systems in anti-cancer drug design. We set out the value of narratives relating to cancer in promoting awareness of risky behaviour and in supporting decision-making regarding treatment options. We present
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fea0373b3e34000410423bc0be0099f0
https://doi.org/10.1007/978-3-319-64714-2_18
https://doi.org/10.1007/978-3-319-64714-2_18
Autor:
Peter R. Moult, Ibrahim H. Kankia, Simon P. Langdon, James L. Bown, Yusuf Y. Deeni, Hilal S. Khalil
Publikováno v:
Kankia, I H, Langdon, S, Khalil, H S, Moult, P R, Bown, J & Deeni, Y 2017, ' Nrf2 Regulates Her1 Signaling Pathway To Modulate The Sensivity Of Ovarian Cancer Cells To Lapatinib And Erlotinib ', Oxidative Medicine and Cellular Longevity . https://doi.org/10.1155/2017/1864578
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2017 (2017)
Oxidative Medicine and Cellular Longevity
Oxidative Medicine and Cellular Longevity, Vol 2017 (2017)
NF-E2-related factor 2 (NRF2) regulates the transcription of a battery of metabolic and cytoprotective genes. NRF2 and epidermal growth factor receptors (EGFRs/HERs) are regulators of cellular proliferation and determinants of cancer initiation and p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47cae1f8bea0aff20028b6091cead2b6
https://hdl.handle.net/20.500.11820/eb318805-357a-4f38-b9ff-84c1a5185591
https://hdl.handle.net/20.500.11820/eb318805-357a-4f38-b9ff-84c1a5185591